|
業務類別
|
Biotechnology |
|
業務概覽
|
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901. |
| 公司地址
| 1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036 |
| 電話號碼
| +1 844 967-2633 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.oramed.com |
| 員工數量
| 13 |
| Dr. Miriam Kidron,PhD |
Director and Chief Scientific Officer |
美元 408.10K |
26/03/2026 |
| Mr. Nadav Kidron |
President, Chief Executive Officer and Chairman of the Board |
美元 540.15K |
26/03/2026 |
| Mr. Avraham Gabay |
Chief Financial Officer, Treasurer, Secretary and Principal Accounting Officer |
-- |
26/03/2026 |
| Mr. Joshua Hexter |
Chief Operating and Business Officer |
美元 259.04K |
26/03/2026 |
|
|
| Dr. Daniel Aghion |
Independent Director |
26/03/2026 |
| Dr. Miriam Kidron,PhD |
Director and Chief Scientific Officer |
26/03/2026 |
| Mr. Benjamin Shapiro |
Independent Director |
26/03/2026 |
| Mr. Yehuda Reznick |
Independent Director |
26/03/2026 |
| Mr. Nadav Kidron |
President, Chief Executive Officer and Chairman of the Board |
26/03/2026 |
| Dr. Arie Mayer, PhD |
Independent Director |
26/03/2026 |
|
|
|
|
